Search Form
First, enter a politician or zip code
Now, choose a category
 

Richard Blumenthal's Public Statements on Issue: Drugs

Office: U.S. Senate (CT) - Sr, Democratic
Date Title
Issue Position: Seniors
Issue Position: Health Care
Oct. 13, 2014 Blumenthal Calls on National School Boards Association to End Planned Partnership with Big Tobacco Youth Tobacco Prevention Program
May 14, 2014 Letter to Edith Ramirez, Chairman of the Federal Trade Commission, and Willliam J. Baer, Assistant Attorney General for the Antitrust Division of the United States Department of Justice - Regarding Pfizer's Potential Takeover of AstraZeneca
March 28, 2014 Letter to Ray Mabus, Secretary of the Navy - Prohibit Tobacco Sales at Naval Bases, Aboard Ships
March 25, 2014 Letter to Margaret Hamburg, Commissioner of US Food and Drug Administration - FDA Must Regulate E-Cigarettes and Other Nicotine Delivery Products
March 17, 2014 Murphy, Blumenthal Propose Plan to Combat Heroin Epidemic in Connecticut
March 10, 2014 Letter to Barack Obama, President of the United States - Finalize Regulations for Tobacco Products
Feb. 14, 2014 Letter to Dough McMillon, President and Chief Executive Officer, Walmart - Remove Tobacco Products from Stores
Aug. 26, 2013 Blumenthal Reiterates Calls For Further Strengthening Animal Fighting Laws After 367 Animals Are Rescued, 10 Suspects Arrested In Multi-State Dog Fighting Raid
April 26, 2013 Senators Lautenberg, Durbin, Harkin, and Blumenthal Introduce Legislation to Stop Tobacco Smuggling, Close Tobacco Tax Loopholes, and Increase Federal Tobacco Taxes
March 22, 2013 Letter to Food and Drug Administration (FDA) Commissioner Margaret Hamburg - Develop Tobacco Warning Labels
March 21, 2013 Letter to Margaret Hamburg, U.S. Food and Drug Administration Commissioner - Contaminated Drugs in CT Hospital
Oct. 11, 2012 Letter to The Honorable Eric H. Holder, Jr., The Attorney General
Oct. 8, 2012 Letter to Commissioner Hamburg
Sept. 21, 2012 Senators Blumenthal, Kohl, Grassley Seek to Protect the Elderly and Taxpayers from Abusive Overprescribing of Antipsychotics
June 26, 2012 Blumenthal Hails Final Passage of Fda Safety and Innovation Act, Highlights 13 Provisions Included in Legislation
June 15, 2012 Letter to the Honorable Tom Harkin, Chairman on the Committee on Health, Education, Labor, and Pensions, the Honorable Michael B. Enzi, Ranking Member Committee on Health, Education, Labor, and Pensions, the Honorable Fred Upton, Chairman on the Committee on Energy and Commerce, and the Honorable Henry A. Waxman Ranking Member Committee on Energy and Commerce
May 24, 2012 Blumenthal Hails Senate Passage of the FDA Safety and Innovation Act, Highlights Key Consumer Provisions He Introduced
May 22, 2012 Kohl, Grassley and Blumenthal Seek to Cut Misuse of Antipsychotics
May 2, 2012 Senators Respond to New Data on Tobacco Tax Loophole
March 30, 2012 Blumenthal Applauds New Food and Drug Administration Guidelines on Big Tobacco
March 9, 2012 Letter to John T. Standley, President and Chief Executive Officer of Rite Aid Pharmacy - Deceptive Marketing Practices
March 8, 2012 Letter to Mr. John T. Standley, President and Chief Executive Officer, Rite Aid Pharmacy
March 8, 2012 Senators: Surgeon General's Report on Youth Smoking Epidemic a Call to Action For State and Federal Government
March 7, 2012 Letter to Margaret Hamburg, Commissioner of the Food and Drug Administration
Feb. 17, 2012 Letter to George Doyle III, President and Chief Operating Officer of Ben Venue Laboratories
Feb. 16, 2012 Letter to George Doyle III, President and Chief Operating Officer of Ben Venue Laboratories
Feb. 8, 2012 The Hill - Innovation Key to Fighting 'SuperBugs'
Feb. 1, 2012 Mikulski, Senate And House Leaders, Introduce Bipartisan Legislation To Fight Chronic Health Conditions
Jan. 26, 2012 Citizens United Anniversary
Jan. 17, 2012 Blumenthal Statement on Disclosure of Drug Company Payments to Doctors
Jan. 4, 2012 Blumenthal Drug Shortage Survey Exposes Damaging Effects in CT
Dec. 22, 2011 Letter to Mark Emmert, President, The National Collegiate Athletic Association
Dec. 16, 2011 Feinstein, Grassley Bill to Combat Transnational Organized Crime Passes the Senate
Dec. 15, 2011 New GAO Report Blumenthal Requested Reveals Growing Number of Life Threatening Drug Shortages
Dec. 15, 2011 Letter to The Honorable Margaret Hamburg, Commissioner Food and Drug Administration
Dec. 8, 2011 Statement on Judiciary Committee Approval and Passage of Counterfeit Drug Legislation
Nov. 30, 2011 Blumenthal Calls for End to Over Prescription of Antipsychotic Drugs in Nursing Homes
Nov. 17, 2011 Proposal for Bipartisan, Bicameral Bill To Increase Penalties For Counterfeit Drugs
Nov. 17, 2011 Meehan Introduces Bill Boosting Penalties for Rx Drug Counterfeiting
Nov. 2, 2011 Rebuild America Jobs Act
Oct. 31, 2011 Blumenthal Praises President's Executive Order to Address Drug Shortage Crisis
Oct. 21, 2011 Blumenthal Applauds DEA Decision to Put Bath Salts on Controlled Substances List
Oct. 14, 2011 Letter to Mary Hamburg, Commisioner of the Food and Drug Administration
Sept. 26, 2011 Letter to Secretary Sebelius, Health and Human Services
July 21, 2011 Blumenthal Calls for Measures to Lower Drug Prices for Seniors
July 8, 2011 Blumenthal Visits Connecticut Children's Medical Center to Discuss Threat of Drug Resistant Infections
June 16, 2011 Letter to The Honorable Margaret Hamburg, Commissioner, Food and Drug Administration
May 4, 2011 Letter to Mr. Gene L. Dodaro, Comptroller, U.S. Government Accountability Office (GAO)
Skip to top
Back to top